BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10411481)

  • 1. Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study.
    Vassiliou S; Mucha A; Cuniasse P; Georgiadis D; Lucet-Levannier K; Beau F; Kannan R; Murphy G; Knäuper V; Rio MC; Basset P; Yiotakis A; Dive V
    J Med Chem; 1999 Jul; 42(14):2610-20. PubMed ID: 10411481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.
    Tamura Y; Watanabe F; Nakatani T; Yasui K; Fuji M; Komurasaki T; Tsuzuki H; Maekawa R; Yoshioka T; Kawada K; Sugita K; Ohtani M
    J Med Chem; 1998 Feb; 41(4):640-9. PubMed ID: 9484512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
    Ye Y; Liu M; Kao JL; Marshall GR
    Biopolymers; 2008 Jan; 89(1):72-85. PubMed ID: 17910046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of potent and selective phosphinic peptide inhibitors of angiotensin-converting enzyme 2.
    Mores A; Matziari M; Beau F; Cuniasse P; Yiotakis A; Dive V
    J Med Chem; 2008 Apr; 51(7):2216-26. PubMed ID: 18324760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diastereoselective solution and multipin-based combinatorial array synthesis of a novel class of potent phosphinic metalloprotease inhibitors.
    Makaritis A; Georgiadis D; Dive V; Yiotakis A
    Chemistry; 2003 May; 9(9):2079-94. PubMed ID: 12740857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of matrix metalloproteinases by peptidyl hydroxamic acids.
    Odake S; Morita Y; Morikawa T; Yoshida N; Hori H; Nagai Y
    Biochem Biophys Res Commun; 1994 Mar; 199(3):1442-6. PubMed ID: 8147888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design and combinatorial evaluation of enzyme inhibitor scaffolds: identification of novel inhibitors of matrix metalloproteinases.
    Szardenings AK; Harris D; Lam S; Shi L; Tien D; Wang Y; Patel DV; Navre M; Campbell DA
    J Med Chem; 1998 Jun; 41(13):2194-200. PubMed ID: 9632351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry.
    Jirácek J; Yiotakis A; Vincent B; Lecoq A; Nicolaou A; Checler F; Dive V
    J Biol Chem; 1995 Sep; 270(37):21701-6. PubMed ID: 7665587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent, achiral matrix metalloproteinase inhibitors.
    Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Rydel T; Dunaway CM; Gu F; Mieling GE
    J Med Chem; 1998 Sep; 41(19):3568-71. PubMed ID: 9733482
    [No Abstract]   [Full Text] [Related]  

  • 10. Matrix metalloproteinase inhibitors: a structure-activity study.
    Levy DE; Lapierre F; Liang W; Ye W; Lange CW; Li X; Grobelny D; Casabonne M; Tyrrell D; Holme K; Nadzan A; Galardy RE
    J Med Chem; 1998 Jan; 41(2):199-223. PubMed ID: 9457244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human stromelysin by peptides based on the N-terminal domain of tissue inhibitor of metalloproteinases-1.
    Hanglow AC; Lugo A; Walsky R; Visnick M; Coffey JW; Fotouhi N
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1156-63. PubMed ID: 7802645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state.
    Gall AL; Ruff M; Kannan R; Cuniasse P; Yiotakis A; Dive V; Rio MC; Basset P; Moras D
    J Mol Biol; 2001 Mar; 307(2):577-86. PubMed ID: 11254383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of highly selective inhibitors of collagenase-1 from combinatorial libraries of diketopiperazines.
    Szardenings AK; Antonenko V; Campbell DA; DeFrancisco N; Ida S; Shi L; Sharkov N; Tien D; Wang Y; Navre M
    J Med Chem; 1999 Apr; 42(8):1348-57. PubMed ID: 10212120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors.
    Jacobsen EJ; Mitchell MA; Hendges SK; Belonga KL; Skaletzky LL; Stelzer LS; Lindberg TJ; Fritzen EL; Schostarez HJ; O'Sullivan TJ; Maggiora LL; Stuchly CW; Laborde AL; Kubicek MF; Poorman RA; Beck JM; Miller HR; Petzold GL; Scott PS; Truesdell SE; Wallace TL; Wilks JW; Fisher C; Goodman LV; Kaytes PS
    J Med Chem; 1999 May; 42(9):1525-36. PubMed ID: 10229623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases.
    Levin JI; DiJoseph JF; Killar LM; Sharr MA; Skotnicki JS; Patel DV; Xiao XY; Shi L; Navre M; Campbell DA
    Bioorg Med Chem Lett; 1998 May; 8(10):1163-8. PubMed ID: 9871728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.
    Grams F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi V; Menta E; Oliva A; Zimmermann G; Gram F; Brandstetter H; D'Alò S; Geppert D; Krell HW; Leinert H; Livi VMenta E; Oliva A; Zimmermann G
    Biol Chem; 2001 Aug; 382(8):1277-85. PubMed ID: 11592410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational and solvation studies via computer simulation of the novel large scale diastereoselectively synthesized phosphinic MMP inhibitor RXP03 diluted in selected solvents.
    Matziari M; Dellis D; Dive V; Yiotakis A; Samios J
    J Phys Chem B; 2010 Jan; 114(1):421-8. PubMed ID: 20014753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and activity of phosphinic tripeptide inhibitors of cathepsin C.
    Mucha A; Paweł M; Hurek J; Kafarski P
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3113-6. PubMed ID: 15149655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.
    Hanessian S; Moitessier N; Gauchet C; Viau M
    J Med Chem; 2001 Sep; 44(19):3066-73. PubMed ID: 11543675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of potent inhibitors of botulinum neurotoxin type B.
    Anne C; Turcaud S; Quancard J; Teffo F; Meudal H; Fournié-Zaluski MC; Roques BP
    J Med Chem; 2003 Oct; 46(22):4648-56. PubMed ID: 14561084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.